Full text is available at the source.
Unveiling Butyrate as a Parkinson’s Disease Therapy
Butyrate as a potential treatment for Parkinson's disease
AI simplified
Abstract
Butyrate, a short-chain fatty acid, is linked to reduced intestinal permeability and increased systemic inflammation.
- A decrease in butyrate-producing bacteria is associated with lower butyrate levels.
- Reduced butyrate levels may contribute to increased intestinal permeability and systemic inflammation.
- Butyrate has a potential therapeutic role in Parkinson's Disease.
- The review discusses butyrate's functions and mechanisms in the gut and its impact on the gut-brain axis.
- Effects of butyrate supplementation are examined in both animal models and human clinical studies.
AI simplified